30.09.2018 • NewsElaine BurridgeLenzing

Lenzing Suspends US Lyocell Project

Lenzing Suspends US Lyocell Project (c) Lenzing
Lenzing Suspends US Lyocell Project (c) Lenzing

Austrian fibers producer Lenzing has decided to temporarily mothball its lyocell expansion project in Mobile, Alabama, USA.

The company said the rising likelihood of increasing trade tariffs along with a potential surge in construction costs from a buoyant US labor market have increased the risk profile of the project.

Lenzing originally intended to invest $293 million to build a 90,000 t/y Tencel fiber plant at Mobile, with completion due in the first quarter of 2019.

As a result of its decision, Lenzing said it will now focus its efforts on readjusting its growth plan to meet strong market demand for lyocell fibers. This includes an increased focus on its expansion project in Prachinburi, Thailand, which the company announced in June 2017. A new plant, designed to produce up to 100,000 t/y, is scheduled for completion at end 2020.

The company said it will reassess its decision on an ongoing basis although stated that it will add no substantial volumes for lyocell in 2019 and 2020, over and above the previously announced 25,000 t/y expansion in Heiliigenkreuz, Austria.

Lenzing added that it remained on track with its expansions for specialty fibers Tencel Luxe and Ecovero. In May 2018, it announced a €30 million investment in a further pilot plant at Lenzing for Tencel Luxe along with the start of production in China for its Ecovero viscose fibers.

The Austrian group is aiming to raise specialty fibers’ share of its revenue from 42% currently to 50% by 2020.

 

 

Company

Logo:

Lenzing AG

Werkstr. 2
4860 Lenzing
Austria

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.